Update from Sacla regarding pesto recall
20th January 2020
The Anaphylaxis Campaign has received and has been asked to share the following update from Sacla regarding its recent pesto recall. Update from Sacla: Customer health and safety is always our number one priority. In December, when we became aware that cashew nuts used in some of our pesto recipes, sent to us by an external supplier, may […]
Read More...Statement Regarding the Inquest of Shante Turay-Thomas
13th January 2020
The Coroner has ended the inquest into the death of Shante Turay-Thomas and has delivered her narrative determination and highlighted the contents of the Prevention of Future Deaths report that she will deliver. The Anaphylaxis Campaign would like to extend our deepest condolences to the family of Shante, who died aged 18 at her home […]
Read More...Statement regarding the death of Ken Matthews
6th January 2020
The Anaphylaxis Campaign is saddened to learn of the death of Ken Matthews, 84, who died at Wrexham Maelor Hospital on 2 June 2019. Consultant pathologist Dr Huyen Abdel Salam told the inquest that Mr Matthews died of an allergic reaction. According to press reports Ken was not known to have any existing allergies and […]
Read More...Prosecution case: Hertfordshire restaurant fined after customer suffered severe allergic reaction
16th December 2019
The Artichoke, Croxley Green, has been fined £23,000 after being prosecuted by Hertfordshire Trading Standards when one of its customers became seriously ill. Hertfordshire County Council said KOB (The Artichoke) Ltd pleaded guilty to offences under the Food Safety Act 1990 and Food Safety and Hygiene (England) Regulations 2013 at Luton Magistrates’ Court on Monday […]
Read More...EAT Study shows early exposure to allergens could stop allergies developing
6th December 2019
New findings from the London-based EAT Study have shown that giving certain allergenic foods to specific groups of babies at high risk of developing allergies, from as young as three months could reduce the likelihood of them developing an allergy to those foods. The original EAT study (2016) placed more than 1,300 babies at random […]
Read More...MHRA issues Emerade Alert Update
28th November 2019
Thursday 28th November 2019 The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received reports of Emerade pens failing to activate. This means that in some cases, the needle is not released, and the injection of adrenaline is not delivered. This alert is an update to the previous drug alert issued […]
Read More...EpiPen 0.3mg Auto-Injectors have Longer Shelf Life
15th November 2019
EpiPen 0.3mg auto-injector devices have now had their shelf life increased from 20 months to 24 months from the date of manufacture. Expiry dates can be found on the label on the auto-injector device and should not be used after this date. The shelf life for EpiPen 0.15mg auto-injector devices remains at 19 months from […]
Read More...Latest NHS Digital Figures Show an Increase in Anaphylaxis Hospital Admissions in Children and Adults
15th November 2019
Latest figures reveal that hospital admissions for anaphylactic shock for all causes has risen by around 70% in the past five years, from 2013-2014 to 2018-2019, for under 18’s, as shown in the graph below. Hospital admissions for anaphylactic shock for adults has also increased from 3,092 to 3,751 in the same five-year period. See […]
Read More...Statement Regarding the Death of Dennis Walsh
6th November 2019
The Anaphylaxis Campaign is saddened to learn of the death of Dennis Walsh, a 70-year-old who died due to a severe anaphylactic reaction to the contrast dye used during a CT scan on 8 August 2019 at Royal Blackburn Hospital. An inquest into his death held at Blackburn Town Hall on 30 October heard that […]
Read More...IMPORTANT UPDATE: UK Supply of Imported Jext® 300mcg Adrenaline Auto-Injectors from Austria
24th October 2019
We have received the following statement from ALK regarding imported Jext® 300mcg Adrenaline Auto-Injectors from Austria which aim to support and maintain the overall supply in the UK market. There are supply issues affecting some brands of adrenaline auto-injectors on the UK market. To support and maintain an overall adequate supply, ALK has obtained acceptance from […]
Read More...